Aviva’s Clarivate CLVT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q4
Sell
-497,404
Closed -$3.34M 966
2023
Q3
$3.34M Sell
497,404
-1,848
-0.4% -$14.7K 0.01% 552
2023
Q2
$4.76M Buy
499,252
+283,068
+131% +$2.4M 0.02% 522
2023
Q1
$2.03M Buy
216,184
+151,972
+237% +$1.57M 0.01% 660
2022
Q4
$536K Sell
64,212
-1,195
-2% -$11.2K ﹤0.01% 951
2022
Q3
$614K Sell
65,407
-108
-0.2% -$1.37K ﹤0.01% 941
2022
Q2
$908K Sell
65,515
-14,753
-18% -$221K ﹤0.01% 976
2022
Q1
$1.34M Sell
80,268
-49,398
-38% -$819K 0.01% 941
2021
Q4
$3.05M Sell
129,666
-912
-0.7% -$21.1K 0.01% 696
2021
Q3
$2.86M Sell
130,578
-2,026
-2% -$49.3K 0.01% 699
2021
Q2
$3.65M Buy
132,604
+71,756
+118% +$1.97M 0.02% 665
2021
Q1
$1.61M Buy
+60,848
New +$1.66M 0.01% 717

Other funds holding CLVT

Aviva's CLVT Position: Q4 2023 in Review

Aviva sold out of Clarivate (CLVT) in Q4 2023, closing a stake of 497,404 shares — an estimated $3.34M sold.

Aviva first reported a position in CLVT in Q1 2021 and held it in 11 quarters. The position peaked at $4.76M in Q2 2023. 217 funds tracked by Wall St. Rank hold CLVT as of Q4 2023.

  • Aviva reported no remaining Clarivate position as of Q4 2023 after selling out during the quarter.
  • Aviva sold 497,404 Clarivate shares in Q4 2023, an estimated $3.34M.
  • Aviva first reported a position in Clarivate in Q1 2021 and held it in 11 quarters.
  • Aviva's Clarivate position peaked at $4.76M in Q2 2023.
  • 217 funds tracked by Wall St. Rank held Clarivate as of Q4 2023.

Based on Aviva's 13F filing for Q4 2023, filed 9 Feb 2024.